Beatriz da Silva Lopes Martins — University of Helsinki

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fields of Science

317 Pharmacy

16 Article
2 Review Article
1 Meeting Abstract

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
Fusciello, M., Ylösmäki, E., Feola, S., Uoti, A., Martins, B., Aalto, K., Hamdan, F., Chiaro, J., Russo, S., Viitala, T. & Cerullo, V., 16 Jun 2022, In: Molecular Therapy - Oncolytics. 25, p. 137-145 9 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines
Feola, S., Chiaro, J., Martins, B., Russo, S., Fusciello, M., Ylösmäki, E., Bonini, C., Ruggiero, E., Hamdan, F., Feodoroff, M., Antignani, G., Viitala, T., Pesonen, S., Grönholm, M., Branca, R. M. M., Lehtiö, J. & Cerullo, V., 22 Mar 2022, In: eLife. 11, 21 p., 71156.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine
Feola, S., Russo, S., Martins, B., Lopes, A., Vandermeulen, G., Fluhler, V., De Giorgi, C., Fusciello, M., Pesonen, S., Ylösmäki, E., Antignani, G., Chiaro, J., Hamdan, F., Feodoroff, M., Grönholm, M. & Cerullo, V., 14 Apr 2022, In: Frontiers in Immunology. 13, 16 p., 826164.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
Ylösmäki, E., Ylösmäki, L., Fusciello, M., Martins, B., Ahokas, P., Cojoc, H., Uoti, A., Feola, S., Kreutzman, A., Ranki, T., Karbach, J., Viitala, T., Priha, P., Jäger, E., Pesonen, S. & Cerullo, V., 26 Mar 2021, In: Molecular Therapy - Oncolytics. 20, p. 459-469 11 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses
Hamdan, F., Martins, B., Feodoroff, M., Giannoula, Y., Feola, S., Fusciello, M., Chiaro, J., Antignani, G., Grönholm, M., Ylösmaki, E. & Cerullo, V., 12 Mar 2021, In: Molecular therapy-Methods & clinical development. 20, p. 625-634 10 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access